JPMORGAN CHASE & CO - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 2 filers reported holding ONCOCYTE CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2023$714
-28.6%
3,1040.0%0.00%
Q1 2023$1,000
+99900.0%
3,1040.0%0.00%
Q4 2022$1
-100.0%
3,104
-60.2%
0.00%
Q3 2022$6,0000.0%7,808
+22.7%
0.00%
Q2 2022$6,000
-89.8%
6,362
-84.1%
0.00%
Q1 2022$59,000
-14.5%
39,914
+25.0%
0.00%
Q4 2021$69,000
-18.8%
31,926
+34.2%
0.00%
Q3 2021$85,000
-77.0%
23,795
-63.1%
0.00%
Q2 2021$370,000
-43.5%
64,526
-48.9%
0.00%
Q1 2021$655,000
+169.5%
126,244
+24.5%
0.00%
Q4 2020$243,000
+252.2%
101,384
+110.0%
0.00%
Q3 2020$69,000
-2.8%
48,279
+31.0%
0.00%
Q2 2020$71,000
-22.0%
36,865
-0.1%
0.00%
Q1 2020$91,000
+44.4%
36,905
+31.9%
0.00%
Q4 2019$63,000
+215.0%
27,972
+192.8%
0.00%
Q3 2019$20,000
+33.3%
9,553
+61.8%
0.00%
Q2 2019$15,000
-91.7%
5,904
-87.1%
0.00%
Q1 2019$181,00045,773
+15469.0%
0.00%
Q4 2018$0
-100.0%
294
-2.3%
0.00%
Q3 2018$1,0000.0%3010.0%0.00%
Q2 2018$1,000
-50.0%
301
-60.6%
0.00%
Q1 2018$2,000
-60.0%
764
-27.2%
0.00%
Q4 2017$5,0001,050
+2042.9%
0.00%
Q1 2017$0490.0%0.00%
Q4 2016$0490.00%
Other shareholders
ONCOCYTE CORP shareholders Q3 2023
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 17,349,945$61,766,0003.15%
Defender Capital, LLC. 1,960,820$6,935,0002.26%
Millrace Asset Group, Inc. 613,885$2,185,0001.36%
PURA VIDA INVESTMENTS, LLC 12,223,953$43,517,0001.32%
Penbrook Management LLC 577,200$2,055,0001.28%
ACT CAPITAL MANAGEMENT, LLC 330,000$1,175,0000.61%
AWM Investment Company, Inc. 717,000$2,553,0000.25%
Colonial River Wealth Management, LLC 66,200$218,0000.15%
CALIBER WEALTH MANAGEMENT, LLC 66,200$218,0000.15%
Fort Sheridan Advisors LLC 110,000$392,0000.13%
View complete list of ONCOCYTE CORP shareholders